Webcast - 2021 Updates in Hematologic Malignancies

This accredited continuing education activity “Webcast 2021 Updates in Hematologic Malignancies”, is recorded from the live meeting held on 10/02/2021 at the Hilton Salt Lake City Center in Salt Lake City. 

If you participated in the live meeting titled - 2021 Updates in Hematologic Malignancies on 10/02/2021 in Salt Lake City and claimed CME credits/MOC points for that activity, you do not qualify for CME credits/MOC points for your participation in this enduring activity. This is a recorded content from that conference on 10/02/2021.  However, you may enroll in this activity to review the contents. 

 

REGISTRATION FEES:

This activity is free for all healthcare providers who are not employees of an ineligible entity. Please select "non-industry learner" when you are ready to register for the course, and the price will reset to $0. 

Healthcare providers ($0.00)

Industry employees ($200 + 3% Credit card fee) 

If you are a healthcare provider involved in patient care and you are not employed by the Industry, then you don't pay anything to register for this activity.

If you are employed by industry, you must pay a registration fee to participate in these meetings. Any unpaid industry registrations will be invoiced $412 per participant.

If you paid to join the live meeting associated with this webcast and wish to register for this enduring material please contact us and we will register you for free.

Target Audience

  • Hematologists/Oncologists
  • Oncology Nurse Practitioners
  • Oncology Pharmacists
  • Oncology Physician Assistants
  • Oncology Fellows/Residents
  • Oncology Nurses
  • Researchers and others involved in the care of cancer patients

Learning Objectives

Upon successful completion of this educational activity, participants will be able to:

  • Review pertinent clinical trial data for the standard of care and novel management strategies for various hematologic malignancies.
  • Integrate and optimally sequence evidence-based treatment plans for various hematologic malignancies based on patient and tumor factors.
  • Discuss the mechanism of action, efficacy, indications, and safety of novel targeted therapies and cellular therapies for the management of hematologic malignancies.
  • Review current controversies in the management of various hematologic malignancies.
  • List appropriate clinical trials for hematologic malignancies
Course summary
Available credit: 
  • 5.00 ABIM MOC II
    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 5.00 Medical Knowledge points in the American Board of Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
  • 5.00 AMA PRA Category 1 Credit™
    The Binaytara Foundation is accredited by the Washington State Medical Association to provide continuing medical education for physicians. The Binaytara Foundation designates this live activity for a maximum of 5.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity meets the criteria for up to 5.00 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.
  • 5.00 Nursing Contact Hours
    Provider approved by the California Board of Registered Nursing, Provider # CEP17035, for 5.00 Contact Hours.
Course opens: 
10/28/2021
Course expires: 
10/28/2022
Cost:
$1.00

This educational activity features recorded videos from the live conference titled - 2021 Updates in Hematologic Malignancies held on 10/2/2021 at the Hilton Salt Lake City Center in Utah.

The videos are placed in the following order. Feel free to view the content that is relevant to you.

Participants should claim continuing education credits to the extent of their participation.


Session 1: Lymphomas

Moderator: Lindsay Fitzgerald, MD

25 minutes Hodgkin lymphoma – Harsh Shah, DO

25 minutes Aggressive lymphomas – Ryan Lynch, MD

25 minutes Chronic lymphocytic leukemia – Deborah Stephens, DO

27 minutes CAR-T cell therapy for the treatment of Lymphoma – Catherine Lee, MD 


Session 2: Leukemias 

Moderator: Ashley Newland, PharmD 

27 minutes: Acute Myeloid Leukemia – Krishna Gundabolu, MD

26 minutes: Acute lymphoblastic leukemia – Tibor Kovacsovics, MD 

16 minutes: Case-based discussion - Charlotte Wagner, PharmD


Session 3: Multiple Myeloma 

Moderator: Douglas Sborov, MD

25 minutes: Front line therapy for newly diagnosed multiple myeloma – Ghulam Mohyuddin, MD 

24 minutes: Treatment of relapse/refractory multiple myeloma - Shaji Kumar, MD

13 minutes: Case-based discussion - Aman Godara, MD 

5 minutes: Case-based discussion - Mary Steinbach, APRN


Session 4: Myeloproliferative Neoplasms

Moderators: Tashi Tsewang, MD 

30 minutes: Myeloproliferative neoplasms – Srinivas Tantravahi, MD                    

25 minutes: Treatment free remission in chronic myeloid leukemia – Jerry Radich, MD                                               

10 minutes: Case-based discussion - Laura Bickel, APRN 

SRINIVAS TANTRAVAHI, MD

Assistant Professor of Medicine

University of Utah 

Learn More

JERALD RADICH, MD

Professor of Medicine

University of Washington, SCCA, Fred Hutch 

Learn More

AMANDEEP GODARA, MD

Assistant Professor of Medicine

Huntsman Cancer Institute, University of Utah

Learn More

TSEWANG TASHI, MD

Assistant Professor of Medicine

Huntsman Cancer Institute, University of Utah

Learn More

KRISHNA GUNDABOLU, MD

Assistant Professor of Medicine

University of Nebraska

Learn More

 

 

HARSH SHAH, DO

Assistant Professor of Medicine

Huntsman Cancer Institute, University of Utah

Learn More

RYAN LYNCH, MD

Assistant Professor of Medicine

University of Washington

Medical-Oncologist

Seattle Cancer Care Alliance

Learn More

 

DEBORAH STEPHENS, DO

Assistant Professor of Medicine

Huntsman Cancer Institute, University of Utah

Learn More

CATHERINE LEE, MD

Assistant Professor of Medicine

Huntsman Cancer Institute, University of Utah

Learn More

TIBOR KOVACSOVICS, MD

Professor of Medicine

Huntsman Cancer Institute, University of Utah

Learn More

DOUGLAS SBOROV, MD

Assistant Professor of Medicine

Huntsman Cancer Institute, University of Utah

Learn More

 

SHAJI KUMAR, MD

Professor of Medicine

Mayo Clinic

Learn More

Photo coming soon!

CHAROLETTE WAGNER, PHARMD

Huntsman Cancer Institute, University of Utah

Learn More

LAURA BICKEL, APRN

Advanced Practice Clinician

Huntsman Cancer Institute, University of Utah

Learn More

MARY STEINBACH, APRN

Advanced Practice Clinician

Huntsman Cancer Institute, University of Utah

Learn More

The Binaytara Foundation is accredited by the Washington State Medical Association to provide continuing medical education for physicians.

The Binaytara Foundation designates this enduring activity for a maximum of 5.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity meets the criteria for up to 5.00 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.

Nursing Contact Hours: Provider approved by the California Board of Registered Nursing, Provider # CEP17035, for 5.00 Contact Hours.

ABSM Maintenance of Certificate Recognition Statement: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 5.00 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Important Information about Claiming CME for this activity:

If you participated in the live meeting titled - 2021 Updates in Hematologic Malignancies on 10/02/2021 in Salt Lake City and claimed CME credits/MOC points for that activity, you do not qualify for CME credits/MOC points for your participation in this enduring activity. This is a recorded content from that conference on 10/02/2021.  However, you can still enroll in this activity and review the contents as needed.

Available Credit

  • 5.00 ABIM MOC II
    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 5.00 Medical Knowledge points in the American Board of Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
  • 5.00 AMA PRA Category 1 Credit™
    The Binaytara Foundation is accredited by the Washington State Medical Association to provide continuing medical education for physicians. The Binaytara Foundation designates this live activity for a maximum of 5.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity meets the criteria for up to 5.00 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.
  • 5.00 Nursing Contact Hours
    Provider approved by the California Board of Registered Nursing, Provider # CEP17035, for 5.00 Contact Hours.

Price

Cost:
$1.00
Please login or register to take this course.

REGISTRATION FEES:

This activity is free for all healthcare providers who are not employees of an ineligible entity. Please select "non-industry learner" when you are ready to register for the course, and the price will reset to $0. 

Healthcare providers ($0.00)

Industry employees ($200 + 3% Credit card fee) 

If you are a healthcare provider involved in patient care and you are not employed by the Industry, register for free!

If you are employed by industry, you must pay a registration fee to participate in these meetings. Any unpaid industry registrations will be invoiced $412 per participant.

If you paid to join the live meeting and wish to register for this enduring material please contact us and we will register you for free.

Cancellation Policy

You may cancel your enrollment at any time. No credits will be offered if you do not complete all required steps of this activity which include registration, watching the recorded content, and completion of pre & post tests as well as course evaluations.

Refund Policy 

This activity is free for all healthcare providers who are not employees of an ineligible entity.

No refunds will be issued if you have started watching the recorded content.